Kidney Affection in Non Alcaholic Fatty Liver Diseases

计划入组 114 人 · 首次发布于 2020 年 2 月 18 日

Chronic Kidney Disease and Non-alcoholic Fatty Liver Diseases

计划入组 62 人 · 首次发布于 2021 年 3 月 3 日

Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases

计划入组 120 人 · 首次发布于 2020 年 7 月 17 日

non-alcoholic fatty liver disease agent

SIG-XXX

anti-VEGF-B antibody (Non alcoholic fatty liver disease /fatty liver disease)

LIVER INSTITUTE PLLC

United States

National Liver Institute

Egypt

National Liver Institute, Egypt

Insitro and Lilly Partner to Develop AI-Discovered Metabolic Disease Drugs

FDA Approves Rezdiffra (resmetirom) for NASH with Liver Fibrosis

Semaglutide Shows Cardiovascular Benefits in HIV Patients with Fatty Liver Disease in SLIM LIVER Trial